Source:http://linkedlifedata.com/resource/umls/id/C0062073
NCI: A semisynthetic aminoglycoside antibiotic derived from dibekacin with activity against both gram-positive and gram-negative bacteria. Arbekacin is most commonly used in the treatment of multi-resistant bacterial infections.